Nicolas Gendron: Join the Conversation on Antithrombotic Stewardship at ISTH 2026
Nicolas Gendron, Research Fellow and Hematologist at Boston Children’s Hospital, shared a post on LinkedIn:
“We need (more) antithrombotic stewardship in Europe/France.
Excited to be part of this important conversation in just a few weeks!
I’ll be joining experts from the Anticoagulation Forum and International Society on Thrombosis and Haemostasis (ISTH) for the 3rd Antithrombotic Stewardship Summit at ISTH 2026 in Paris, where I’ll be speaking on the panel ‘The Core Elements in Action – Application to Identified Priorities.’
If you’re available the afternoon of on Friday, July 10, consider joining us.
It’s a great opportunity to connect and learn from peers across the globe!
The workshop is free to attend, but space is limited.
Learn more and register here.”
Other posts featuring Nicolas Gendron on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?